))
Digital Politics with Karen Jagoda is a non-partisan podcast featuring thought leaders and industry pioneers with insights about innovative approaches to political campaigns, voter engagement, mobilization, fundraising, persuasion, and GOTV. Topics include the power of mobile devices, leveraging social networks, message testing and targeting, cross-media advertising, grassroots organizing, and big data.
…
continue reading
Empowered Patient Podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, and the emergence of precision medicine. The show covers such topics as aging in place, innovative uses for wearables and sensors, advances in clinical research, applied genetics, drug development, and challenges for connected health entrepreneurs.
…
continue reading
1
Media Bubbles and Voter Behavior with Daniel Scantlebury Resonate
18:18
18:18
Play later
Play later
Lists
Like
Liked
18:18
Daniel Scantlebury, Vice President of Data Science and AI at Resonate, is a seasoned observer of human behavior. He uses his insights to better understand and predict voting behavior. In this age of media bubbles, how voters consume news and form opinions creates even more challenges for campaigns to reach them. We talk about: Use of Predictive Res…
…
continue reading
1
Universal Approach to Cell Therapy Using SNAP-CAR with Dave Mehalick Coeptis Therapeutics TRANSCRIPT
Dave Mehalick, Chairman, Co-Founder, President, and CEO of Coeptis Therapeutics, focuses on developing cell therapies for oncology and respiratory diseases. They aim to create a universal cell therapy that can be used for various types of cancer and move it from a later line of treatment to a frontline therapy. The company has developed a unique CA…
…
continue reading
1
Universal Approach to Cell Therapy Using SNAP-CAR with Dave Mehalick Coeptis Therapeutics
19:11
19:11
Play later
Play later
Lists
Like
Liked
19:11
Dave Mehalick, Chairman, Co-Founder, President, and CEO of Coeptis Therapeutics, focuses on developing cell therapies for oncology and respiratory diseases. They aim to create a universal cell therapy that can be used for various types of cancer and move it from a later line of treatment to a frontline therapy. The company has developed a unique CA…
…
continue reading
1
Unlocking the Power of CRISPR Technology for Drug Development with Ross Bundy CRISPR QC TRANSCRIPT
Ross Bundy, President and CEO of CRISPR QC, shines a light on the current state of CRISPR gene editing technology and how the field has advanced rapidly since the discovery of CRISPR's potential to edit the human genome. The focus of CRISPR technology has primarily been on curing rare and genetic diseases, but there is also potential for targeting …
…
continue reading
1
Unlocking the Power of CRISPR Technology for Drug Development with Ross Bundy CRISPR QC
19:27
19:27
Play later
Play later
Lists
Like
Liked
19:27
Ross Bundy, President and CEO of CRISPR QC, shines a light on the current state of CRISPR gene editing technology and how the field has advanced rapidly since the discovery of CRISPR's potential to edit the human genome. The focus of CRISPR technology has primarily been on curing rare and genetic diseases, but there is also potential for targeting …
…
continue reading
Nicolas Poirier, CEO of OSE Immunotherapeutics, uses immunology and molecular engineering to develop innovative immunotherapies for oncology, inflammation, autoimmune diseases, and organ transplant. The same immune cells, lymphocytes and macrophages, are involved in both immuno-oncology and immuno-inflammation, and OSE aims to re-educate these cell…
…
continue reading
1
Therapeutic Cancer Vaccines with Nicolas Poirier OSE Immunotherapeutics
20:17
20:17
Play later
Play later
Lists
Like
Liked
20:17
Nicolas Poirier, CEO of OSE Immunotherapeutics, uses immunology and molecular engineering to develop innovative immunotherapies for oncology, inflammation, autoimmune diseases, and organ transplant. The same immune cells, lymphocytes and macrophages, are involved in both immuno-oncology and immuno-inflammation, and OSE aims to re-educate these cell…
…
continue reading
1
Tapping Into the Power of Influencers with Ryan Davis People First
19:54
19:54
Play later
Play later
Lists
Like
Liked
19:54
Ryan Davis, Co-Founder and Chief Operating Officer of People First, brings voices from diverse and specialized communities to campaigns to promote candidates and causes. The role of individuals with social media followers and the skills to create content is increasingly relevant to political campaigns trying to reach targeted voters. Influencer mar…
…
continue reading
1
Innovative Blood Collection Device Boosts Participation in Decentralized Clinical Trials with Ben Casavant Tasso TRANSCRIPT
Ben Casavant, Co-Founder and CEO of Tasso, focuses on making diagnostics more accessible to patients that allow collection of blood samples at home. Their customers include pharmaceutical companies conducting research and healthcare providers. Using Tasso's technology in decentralized clinical trials allows for easier recruitment, increased patient…
…
continue reading
1
Innovative Blood Collection Device Boosts Participation in Decentralized Clinical Trials with Ben Casavant Tasso
19:18
19:18
Play later
Play later
Lists
Like
Liked
19:18
Ben Casavant, Co-Founder and CEO of Tasso, focuses on making diagnostics more accessible to patients that allow collection of blood samples at home. Their customers include pharmaceutical companies conducting research and healthcare providers. Using Tasso's technology in decentralized clinical trials allows for easier recruitment, increased patient…
…
continue reading
1
AI-Powered Device Provides Real-Time Screening for Early Detection of Heart Failure Symptoms with Chris Darland Peerbridge Health TRANSCRIPT
Chris Darland, President and CEO of Peerbridge Health, discusses technology breakthroughs that enable early, low-cost detection of heart issues with a cardiac monitor that uses AI to analyze heart rhythms over time to detect patterns that may indicate heart failure. The device is based on ECG technology that drives the Holter monitor and delivers a…
…
continue reading
1
AI-Powered Device Provides Real-Time Screening for Early Detection of Heart Failure Symptoms with Chris Darland Peerbridge Health
19:13
19:13
Play later
Play later
Lists
Like
Liked
19:13
Chris Darland, President and CEO of Peerbridge Health, discusses technology breakthroughs that enable early, low-cost detection of heart issues with a cardiac monitor that uses AI to analyze heart rhythms over time to detect patterns that may indicate heart failure. The device is based on ECG technology that drives the Holter monitor and delivers a…
…
continue reading
1
Partnering with Retail Pharmacies to Make Blood Testing More Convenient and Accessible Dr. David Stein Babson Diagnostics TRANSCRIPT
Dr. David Stein, CEO and Director of Babson Diagnostics, a healthcare technology company that focuses on putting the patient at the center of the blood testing experience, recognizing the importance of blood testing in informing clinical decisions and monitoring health. They aim to redefine blood testing by eliminating the anxiety and inconvenience…
…
continue reading
1
Partnering with Retail Pharmacies to Make Blood Testing More Convenient and Accessible Dr. David Stein Babson Diagnostics
17:28
17:28
Play later
Play later
Lists
Like
Liked
17:28
Dr. David Stein, CEO and Director of Babson Diagnostics, a healthcare technology company that focuses on putting the patient at the center of the blood testing experience, recognizing the importance of blood testing in informing clinical decisions and monitoring health. They aim to redefine blood testing by eliminating the anxiety and inconvenience…
…
continue reading
1
How Private Investigators Work with Wendy Pickering Sullivan
27:43
27:43
Play later
Play later
Lists
Like
Liked
27:43
Wendy Pickering Sullivan, Pickering Sullivan Investigations, joins Deepak Puri, CEO of The Democracy Labs, to pull back the curtain on the job of a private investigator. While a great deal of information is available online, PIs have access to proprietary sources, hard-to-find public records, and the right people to access the right resources. Deep…
…
continue reading
1
Impact of AI on Reducing Waste and Friction in Healthcare Administration with Joan Butters Xsolis TRANSCRIPT
Joan Butters, CEO and Co-Founder of Xsolis works with health systems and health plans to automate medical necessity decisions and improve efficiency. Using data and AI, Xsolis helps clinicians make more informed decisions and reduces manual administrative work, resulting in time and cost savings and improved patient care. Addressing the challenges …
…
continue reading
1
Impact of AI on Reducing Waste and Friction in Healthcare Administration with Joan Butters Xsolis
16:07
16:07
Play later
Play later
Lists
Like
Liked
16:07
Joan Butters, CEO and Co-Founder of Xsolis works with health systems and health plans to automate medical necessity decisions and improve efficiency. Using data and AI, Xsolis helps clinicians make more informed decisions and reduces manual administrative work, resulting in time and cost savings and improved patient care. Addressing the challenges …
…
continue reading
1
Cancer Molecular Profiling Using Next-Generation Sequencing to Treat Rare Diseases with Sanjeev Redekar Apollomics TRANSCRIPT
Sanjeev Redkar, Co-Founder, Executive Director, and President of Apollomics, focuses on difficult-to-treat cancers, such as lung cancer, brain cancer, and leukemias, not served by immune checkpoint inhibitors. Their approach targets the thematic pathway in cancer cells responsible for their growth and proliferation. In their drug development, AI an…
…
continue reading
1
Cancer Molecular Profiling Using Next-Generation Sequencing to Treat Rare Diseases with Sanjeev Redekar Apollomics
17:45
17:45
Play later
Play later
Lists
Like
Liked
17:45
Sanjeev Redkar, Co-Founder, Executive Director, and President of Apollomics, focuses on difficult-to-treat cancers, such as lung cancer, brain cancer, and leukemias, not served by immune checkpoint inhibitors. Their approach targets the thematic pathway in cancer cells responsible for their growth and proliferation. In their drug development, AI an…
…
continue reading
Kristen Helton, CEO and Co-Founder of Herself Health, provides comprehensive primary care designed specifically for women over 65, considering the unique health challenges these women face. The emphasis is on the importance of addressing women's health beyond reproductive health and the need for tailored treatment and screening for conditions that …
…
continue reading
1
Redefining Healthcare for Women Over 65 with Kristen Helton Herself Health
19:07
19:07
Play later
Play later
Lists
Like
Liked
19:07
Kristen Helton, CEO and Co-Founder of Herself Health, provides comprehensive primary care designed specifically for women over 65, considering the unique health challenges these women face. The emphasis is on the importance of addressing women's health beyond reproductive health and the need for tailored treatment and screening for conditions that …
…
continue reading
1
Modifying Macrophages to Overcome Evasion by Cancer Cells and Educate Immune System with Robert Towarnicki SIRPant Immunotherapeutics TRANSCRIPT
Robert Towarnicki, CEO and Co-founder of SIRPant Immunotherapeutics, discusses cancer-specific immunotherapy for aggressive tumors, the role macrophages play in the immune response to cancer, and how cancer cells can shut down this response. SIRPant Immunotherapeutics aims to modify macrophages by reducing SIRPα expression, triggering them to eat c…
…
continue reading
1
Modifying Macrophages to Overcome Evasion by Cancer Cells and Educate Immune System with Robert Towarnicki SIRPant Immunotherapeutics
24:52
24:52
Play later
Play later
Lists
Like
Liked
24:52
Robert Towarnicki, CEO and Co-founder of SIRPant Immunotherapeutics, discusses cancer-specific immunotherapy for aggressive tumors, the role macrophages play in the immune response to cancer, and how cancer cells can shut down this response. SIRPant Immunotherapeutics aims to modify macrophages by reducing SIRPα expression, triggering them to eat c…
…
continue reading
1
Power of AI and Data Analytics to Improve Patient Safety Risk Management with Jeff Surges RLDatix TRANSCRIPT
Jeff Surges, CEO of RLDatix, offers global cloud-based solutions for risk management, compliance management, and regulatory management in healthcare. To address patient safety, Jeff emphasizes the need for a collaborative workforce, data analytics, and AI. RLDatix uses technology to automate information gathering, facilitate incident reporting, and…
…
continue reading
1
Power of AI and Data Analytics to Improve Patient Safety Risk Management with Jeff Surges RLDatix
17:39
17:39
Play later
Play later
Lists
Like
Liked
17:39
Jeff Surges, CEO of RLDatix, offers global cloud-based solutions for risk management, compliance management, and regulatory management in healthcare. To address patient safety, Jeff emphasizes the need for a collaborative workforce, data analytics, and AI. RLDatix uses technology to automate information gathering, facilitate incident reporting, and…
…
continue reading
